Schedule 13G ownership disclosure

INVIVO THERAPEUTICS HOLDINGS CORP.

Security class unavailable · CUSIP: 46186M506

Event date: 2020-04-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-20-003022
Form type
SC 13G
Filer
ARMISTICE CAPITAL, LLC
CIK
CIK 1601086
Filed
Apr 24, 2020
Reporting period
Apr 15, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub